New startup aims to recycle 95% of high-value content…
Solarcycle just landed $6.6 million in venture capital funding to power its giga-scale recycling ambitions.
Stay updated with breaking news from Jesse Simons. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Solarcycle just landed $6.6 million in venture capital funding to power its giga-scale recycling ambitions.
Recent failed clinical trials of a drug designed to clear the mutant Huntingtin protein that causes Huntington's disease (HD) heightens the need for new approaches for the devastating, incurable, progressive neurodegenerative genetic disorder. Scientists at the Buck Institute have found that the targeting the protein called FK506-binding protein 51 or FKBP51 promotes the clearing of those toxic proteins via autophagy, a natural process whereby cells recycle damaged proteins and mitochondria and use them for nutrition.